Statin
treatment may decrease risk for development of type 2 diabetes
Statin treatment may improve cardiovascular
risk profiles for some patients through a decrease in risk for type
2 diabetes, according to a presentation at the American Physiology
Society-sponsored conference, Experimental Biology 2003.
Over the past decade, evidence has accumulated
indicating that nitric oxide may play a key role in control of metabolic
and cardiovascular homeostasis: Mice that do not have the gene for
endothelial nitric oxide synthase are both insulin resistant and
hypertensive.
The current study shows that stimulating nitric
oxide bioavailability with use of statins may represent a new way
to improve metabolic control.
A Swiss research team identified two groups
of mice. The first group showed partial deficiency in enzyme activity;
they were heterozygous for a functional allele. The second group
of mice had no enzyme activity; they were homozygous for the nonfunctional
allele.
Half of the first group was treated with simvastatin,
while the other was fed an inert vehicle (no treatment). Half of
the simvastatin group was fed a high-fat diet for 8 weeks, whereas
the other half received a normal diet. The same dietary steps were
taken for the no treatment mice.
Arterial pressure and insulin sensitivity
were measured at the end of the 8-week period.
A high-fat diet caused both arterial hypertension and insulin resistance
in the heterozygous mice that received inert vehicle. In contrast,
the mice in the simvastatin group that were fed a high-fat diet
did not show either insulin resistance or arterial hypertension.
In the homozygous mice (those without enzyme activity), all of the
mice showed similar levels of insulin resistance and arterial hypertension.
These findings provide the first evidence
that simvastatin can prevent diet-induced arterial hypertension
and insulin resistance in mice with some level of endothelial nitric
oxide synthase activity. The data suggest that simvastatin may improve
cardiovascular risk in some human patients through nitric oxide?mediated
improvements in insulin sensitivity and arterial pressure.
|